One Heart Stories

No surprises along the way

No surprises along the way

 

“I needed a heart valve replacement,” Scott says. “And I probably would have put it off if I didn’t need the hip replacement; I’m really glad I went ahead with it.”

Amy Velderman lives a life of miracles

Amy Velderman lives a life of miracles

 

Amy Velderman lives a life of miracles. She was born with a congenital heart defect in 1960, when heart surgery was not an option for babies. “At first they told my parents that I’d probably die before I was a year old,” she says. “Then they said I’d probably die before I reached school age.”

Landmark research might change how we treat AFib in heart failure patients

Landmark research might change how we treat AFib in heart failure patients

 by 

A landmark study might change the way we treat patients that have both heart failure and atrial fibrillation. Cardiac catheter ablation therapy might benefit thousands of patients by providing better symptom management, higher quality of life, and improved survival rates.

Continuing to beat the odds

Continuing to beat the odds

 

With the ongoing support of Dr. Brickner and his transplant and rehabilitation specialists, Heath Erwin is back to enjoying life.

Heart attack patient rebuilds his health: ‘I’m still running’

Heart attack patient rebuilds his health: ‘I’m still running’

 

UT Southwestern cardiologist Benjamin Levine, M.D., helped 46-year-old pharmacist recover from his heart attack and return to running marathons.

Under pressure: How to use the new blood pressure guidelines

Under pressure: How to use the new blood pressure guidelines

 by 

Learn what the new blood pressure guidelines mean for understanding and controlling your risk for heart and vascular conditions.

Stents do work: A closer look at the ORBITA study data

Stents do work: A closer look at the ORBITA study data

 by 

A small study is raising questions about whether stents work for chest pain. Dr. Dharam Kumbhani says they do and explains what the data really mean.

Aspirin study aspires to settle dosage question

Aspirin study aspires to settle dosage question

 

A new clinical trial called ADAPTABLE, The Aspirin Study is aiming to set the record straight on which of two commonly used daily doses of aspirin is more effective. The three-year study is comparing the benefits and side-effect risks of the two doses.

Walking a fine line: How managing blood clots might change heart attack prevention

Walking a fine line: How managing blood clots might change heart attack prevention

 by 

Data from a new drug trial focused on reducing blood clots might allow more personalized options to prevent heart attacks in high-risk patients.

Four people who should see a preventive cardiologist

Four people who should see a preventive cardiologist

 by 

Dr. Amit Khera discusses how people in these four categories can benefit most from preventive cardiology to lower cholesterol and reduce their risk of heart disease.